Afoxolaner Patent Expiration
About Veterinary Afoxolaner
Afoxolaner is used in a drug marketed by 1 company: Boehringer Lngelheim Animal Health Usa Inc.
Other drugs containing Afoxolaner are: Nexgard .
Veterinary Afoxolaner Patents
Given below is the list of patents protecting Afoxolaner, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| NexGard | US8410153 | 20 Jun, 2028 | BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. |
| NexGard | US7964204 | 25 Jan, 2028 | BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. |
| NexGard | US8623875 | 28 Dec, 2026 | BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. |
| NexGard | US9095138 | 28 Dec, 2026 | BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. |
| NexGard | US8231888 | 28 Dec, 2026 | BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. |
Afoxolaner Petitions
Details of Afoxolaner's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Aurora Pharmaceutical, Inc. | Approved | 02 May, 2024 | The proposed change is for an oral solution ; the RLNAD is approved as soft chewables in 11.3 mg, 28.3 mg, 68 mg, and 136 mg strengths. |
Afoxolaner's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List